Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome

ObjectivesWe investigated the impact of secondary antiphospholipid syndrome (APS) and antiphospholipid antibody (aPL) positivity on the non-thromboembolic clinical manifestations of systemic lupus erythematosus (SLE).MethodsIn total, 224 patients with SLE were studied, of whom 105 were aPL-positive;...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Deák Magdolna
Bocskai Márta
Burcsár Szilárd
Dányi O.
Fekete Z.
Kovács László
Dokumentumtípus: Cikk
Megjelent: 2014
Sorozat:LUPUS 23 No. 9
doi:10.1177/0961203314531839

mtmt:2601977
Online Access:http://publicatio.bibl.u-szeged.hu/9665

Hasonló tételek